Filing Details

Accession Number:
0001566028-13-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-04 14:00:05
Reporting Period:
2013-10-03
Filing Date:
2013-10-04
Accepted Time:
2013-10-04 14:00:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887497 Hi Tech Pharmacal Co Inc HITK Pharmaceutical Preparations (2834) 112638720
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263136 J William Peters C/O Hi-Tech Pharmacal Co., Inc.
369 Bayview Avenue
Amityville NY 11701
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-03 15,000 $18.87 15,000 No 4 M Direct
Common Stock Acquisiton 2013-10-03 6,250 $5.83 21,250 No 4 M Direct
Common Stock Disposition 2013-10-03 21,250 $43.11 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-10-03 15,000 $0.00 15,000 $18.87
Common Stock Stock Option (Right to Buy) Disposition 2013-10-03 6,250 $0.00 6,250 $5.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,750 2006-08-01 2015-08-01 No 4 M Direct
0 2009-11-13 2018-11-13 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.10 to 43.15, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
  2. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
  3. The option became exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
  4. Other than the option to acquire 3,750 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 133,750 shares of Hi-Tech Common Stock (for aggregate options to acquire a total of 137,500 shares of Common Stock), which options were granted on various dates, with varying exercise prices and exercisable and expiration dates.